Skip to content

The Use of Samsung Health and ECG M-Trace Base II Applications in the Secondary Prevention After Stroke

The Use of Samsung Health and ECG M-Trace Base II Applications for the Assessment of Exercise Tolerance as the Secondary Prevention in Patients After Brain Stroke

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04821518
Enrollment
52
Registered
2021-03-29
Start date
2020-11-15
Completion date
2021-03-01
Last updated
2021-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mobile Applications, Secondary Prevention, Stroke

Brief summary

The aim of the present study was to quantitatively assess the risk factors that may affect the re-occurrence of a CVD event and the use of a commercially available mobile application Samsung Health for the assessment of parameters of exercise tolerance and the ECG M-Trace Base II application for the assessment of cardiological parameters.

Detailed description

In the post-stroke group and in the control group, SMWT (Six Minute Walk Test) and SCT( Stair Climb Test) were preceded by a 10-minute rest in sitting position. The time of test performance, the walked distance and steps made as well as the mean and maximum gait velocity and the calories burned were assessed using the above-mentioned Samsung Health application . ECG results were assessed with the use of ECG M-Trace Base II application described above. In addition, cardiological parameters such as: systolic blood pressure (SBP) and diastolic blood pressure (DBP), heart rate (HR) and arterial blood saturation were assessed. The measurements were performed at rest and directly after SCMT and SCT. Additionally, after the tests, the level of dyspnoea and fatigue was assessed according to the modified Borg scale (score 0-10).

Interventions

None listed

Sponsors

Poznan University of Medical Sciences
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
42 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

to the post-stroke group were as follows : 1. occurrence of hemiparesis after the first episode of ischaemic stroke 2. stroke confirmed in the diagnostic imaging records 3. score \>3 on Lovett's scale of muscle strength in the paretic limbs 4. score above 15 in Barthel's scale of performance in activities of daily living 5. score below 12 in the National Institutes of Health Stroke Scale (NIHSS) 6. available complete medical records concerning the assessed risk factors of recurrent CVD event 7. lack of concomitant pulmonary diseases including chronic obstructive pulmonary disease and bronchial asthma

Exclusion criteria

from the post-stroke group were as follows: 1. hemiparesis or tetraparesis following many episodes of stroke, 2. lack of diagnostic imaging scans confirming the occurrence of stroke 3. hospital stay at the Department of Neurological Rehabilitation for more than 14 days from the occurrence of stroke 4. incomplete medical records concerning the assessed risk factors of recurrent CVD event 5. score \>3 on Lovett's scale of muscle strength in the paretic limbs 6. score below 14 in Barthel's scale of performance in activities of daily living 7. score above 13 in the NIHSS scale 8. occurrence of factors limiting walking ability, such as diagnosed pulmonary diseases, unstable angina, severe valvular heart diseases, cardiomyopathy, musculoskeletal or autoimmune diseases.

Design outcomes

Primary

MeasureTime frameDescription
heart rate at restbaselineheart rate per minute
heart rate after SMWTbaselineheart rate per minute
heart rate after SCTbaselineheart rate per minute
heart rhythm at restbaselineheart rhythm interpreting ECG (regular or irregular)
heart rhythm after SMWTbaselineheart rhythm interpreting ECG (regular or irregular)
heart rhythm after SCTbaselineheart rhythm interpreting ECG (regular or irregular)
increased blood pressure at restbaselineblood pressure value \[mm/Hg\]
increased blood pressure after SMWTbaselineblood pressure value \[mm/Hg\]
increased blood pressure after SCTbaselineblood pressure value \[mm/Hg\]
Distance of walk after SMWTbaselineDistance (metres)
Distance of walk after SCTbaselineDistance (metres)
Steps after SMWTbaselineNumber of steps (number)
Steps after SCTbaselineNumber of steps (number)
Velocity of walk after SMWTbaselineMean velocity (km/h)
Velocity of walk after SCTbaselineMean velocity (km/h)

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026